GGrantIndex
← Search

Biorepository Shared Resource

$1P30FY2023CANIH

University Of California At Davis, Davis CA

Investigators

Linked publications, trials & patents

Paper 39725713Paper 39620216Paper 39616300Paper 39488208Paper 39453739Paper 39440945Paper 39384967Paper 39383000Paper 39350111Paper 39345479Paper 39345391Paper 39257973Paper 39252929Paper 39217266Paper 39177582Paper 39168154Paper 39108503Paper 39103353Paper 39056190Paper 39046599Paper 39012466Paper 38990223Paper 38979288Paper 38969563Paper 38947002Paper 38885336Paper 38877132Paper 38865710Paper 38843382Paper 38826195Paper 38803393Paper 38798575Paper 38780011Trial NCT07304011Trial NCT07258446Trial NCT07209215Trial NCT07189195Trial NCT07145112Trial NCT06905509Trial NCT06854159Trial NCT06211335Trial NCT06178354Trial NCT06173362Trial NCT06173349Trial NCT06103682Trial NCT06103669Trial NCT06067776Trial NCT05967533Trial NCT05843448Trial NCT05600686Trial NCT05479578Trial NCT05110781Trial NCT05101356Trial NCT05052528Trial NCT04964505Trial NCT04905810Trial NCT04856189Trial NCT04716699Trial NCT04587687Trial NCT04578600Trial NCT04552704Trial NCT04450173Trial NCT04410302Trial NCT04186988Trial NCT04050085Trial NCT04030559Trial NCT03695250Trial NCT03359460Trial NCT03299088Trial NCT03164486Trial NCT03123978Trial NCT02997761Trial NCT02935205Trial NCT02823990Trial NCT02807805Trial NCT02569723Trial NCT02400814Trial NCT02364609Trial NCT02348255Trial NCT02339168Trial NCT02178241Trial NCT02077998Trial NCT01924260Trial NCT01923337Trial NCT01911507Trial NCT01008566Trial NCT00918645Trial NCT00810719Trial NCT00804310Trial NCT00795665Trial NCT00628654Trial NCT00467077Trial NCT00408499Trial NCT00390429Trial NCT00389922Trial NCT00388115Trial NCT00388089Trial NCT00387660Trial NCT00387322Trial NCT00376727

Abstract

BIOREPOSITORY SHARED RESOURCE (BRSR) PROJECT SUMMARY/ABSTRACT The Biorepository Shared Resource (BRSR) provides well-characterized, high-quality, de-identified specimens with annotated data for clinical and basic science cancer research purposes for members of the UC Davis Comprehensive Cancer Center (UCDCCC). Accredited by the College of American Pathologists (CAP), the BRSR focuses on quality, accuracy, and procedural consistency of biospecimen management upon which research outcomes directly depend. The BRSR functions as a centralized tissue bank to provide UCDCCC members and other researchers access to cancer and non-cancer-related specimens (fresh/frozen tissue, paraffin blocks/sections and fluids), procured and stored using international standards of best practices and protocols compliant with the Office for Human Research Protection. In addition, BRSR supports all clinical trials and other projects such as the U54 University of California Minority Cancer PDX (UCaMP) project, as well as tissue collection and storage for PDX models. The BRSR is centrally located at UCD Health (UCDH) with an office and lab on the second floor of the main hospital, and at the histology lab in the nearby Pathology building. Oversight and management of the BRSR is provided by the Director, Regina Gandour-Edwards, MD, a clinical pathologist with over 30 years of experience as a surgical pathologist and translational researcher; and the manager, Irmgard Feldman, a certified clinical research professional with more than 12 years of experience in specimen collection, processing, biobanking and management. The Specific Aims for the BRSR are to 1) Procure, prepare, store and disperse malignant, benign and normal human biospecimens from a centralized biorepository that are collected using standardized procedures and continuously audited quality management programs. 2) Provide high quality pathological and clinical annotated data using a secure and interactive on-line database system (OpenSpecimen). 3) Ensure compliance with all mandated regulatory processes (HHS, IRB, HIPAA, SRC) thereby promoting ethical research by UCDCCC members and other researchers. 4) Provide experienced pathologic consultation to investigators using human specimens for scientific correlation. 5) Efficiently prioritize, track, and disperse biospecimen requests via a rapid and standardized, web-based approval and monitoring process. 6) Provide Tissue Microarray (TMA) construction and histology services for UCDCCC investigators and their collaborators.

View original record on NIH RePORTER →